miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression.
about
miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
miR-495 sensitizes MDR cancer ...... by inhibiting MDR1 expression.
@en
type
label
miR-495 sensitizes MDR cancer ...... by inhibiting MDR1 expression.
@en
prefLabel
miR-495 sensitizes MDR cancer ...... by inhibiting MDR1 expression.
@en
P2093
P2860
P356
P1476
miR-495 sensitizes MDR cancer ...... by inhibiting MDR1 expression.
@en
P2093
Chaoqun Chen
Chenmin Zhao
Chenyang Qiu
Daoquan Fang
Dengqiang Wu
Jiahui Zhu
Jingsang Hu
P2860
P304
P356
10.1111/JCMM.13114
P577
2017-04-14T00:00:00Z